STAT1h
Vertex’s upcoming sciatica trial readout is a high-stakes moment in its quest to quell pain
VertexPharma wants to transform the treatment of pain. An upcoming sciatica clinical trial readout will be pivotal.
MarketWatch13h
Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
Sigma Planning Corp Has $1.28 Million Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Sigma Planning Corp trimmed its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 8.7% during the third quarter, according to its most recent disclosure with the ...
Prediction: This Biotech Stock Is Heading for a Once-in-a-Generation Opportunity
Vertex has reached a key moment because the U.S. Food and Drug Administration (FDA) is reviewing its candidate, suzetrigine, ...